Sequoia Financial Advisors’s BriaCell Therapeutics Corp Warrant BCTXW Stock Holding History

Sequoia Financial Advisors’s Portfolio BCTXW Stock Details BCTXW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-45,000	Closed	-$111K	–	1206
2023 Q3	$111K	Hold	45,000	–	–	﹤0.01%	914
2023 Q2	$113K	Buy	+45,000	New	+$124K	﹤0.01%	915

Other funds holding BCTXW

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

RAM

Redmond Asset Management Henrico, Virginia $401M AUM 14.95% 1-Year Est. Return

Sequoia Financial Advisors's BCTXW Position: Q4 2023 in Review

Sequoia Financial Advisors sold out of BriaCell Therapeutics Corp Warrant (BCTXW) in Q4 2023, closing a stake of 45,000 shares — an estimated $111K sold.

Sequoia Financial Advisors first reported a position in BCTXW in Q2 2023 and held it in 2 quarters. The position peaked at $113K in Q2 2023. 2 funds tracked by Wall St. Rank hold BCTXW as of Q4 2023.

Sequoia Financial Advisors reported no remaining BriaCell Therapeutics Corp Warrant position as of Q4 2023 after selling out during the quarter.
Sequoia Financial Advisors sold 45,000 BriaCell Therapeutics Corp Warrant shares in Q4 2023, an estimated $111K.
Sequoia Financial Advisors first reported a position in BriaCell Therapeutics Corp Warrant in Q2 2023 and held it in 2 quarters.
Sequoia Financial Advisors's BriaCell Therapeutics Corp Warrant position peaked at $113K in Q2 2023.
2 funds tracked by Wall St. Rank held BriaCell Therapeutics Corp Warrant as of Q4 2023.

Based on Sequoia Financial Advisors's 13F filing for Q4 2023, filed 26 Jan 2024.